C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/226, 260/277
C07D 217/26 (2006.01) C07D 401/00 (2006.01) C07D 403/06 (2006.01) C07F 9/62 (2006.01)
Patent
CA 2009578
The present invention provides novel bicyclic derivatives useful as excitatory amino acid receptor antagonists and in treating a variety of associated nervous system disorders. The bicyclic derivatives have the general formula: (see fig I) wherein: X is -COOH, (see fig II), (see fig. III), (see fig. IV), (see fig. V), -SO2R3, -PO3, (R4)2 or (see fig. VI); one of Y and Z is COOH, (see fig. VII), (see fig. VIII), (see fig. IX), (see fig. X), or (see fig. XI) and the other of Y and Z is hydrogen; each R3 is independently C1 - C16 alkoxy, phenyl-substituted C1 - C4 alkoxy, benzyloxy substituted on the phenyl ring with halogen, C1 - C4 alkyl or C1 - C4 alkoxy; C1 - C5 alkanoyloxymethyl; or C1 - C5 alkanoyloxymethyl substituted on the oxymethyl with C1 - C4 alkyl or C4 - C7 cycloalkyl, and each R4 is independently hydrogen, C1 - C16 alkyl, phenyl-substituted C1 - C4 alkyl, or phenyl; or a pharmaceutically acceptable salt thereof.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Excitatory amino acid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Excitatory amino acid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Excitatory amino acid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1421523